|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 166.70 CHF | +1.89% |
|
+2.40% | +65.64% |
| 12-12 | Swiss stocks - Factors to watch on December 12 | RE |
| 12-11 | Galderma Enrolls Patients in Study of Chronic Pruritus of Unknown Origin Treatment | MT |
| Capitalization | 49.74B 42.31B 39.6B 37.18B 68.47B 4,514B 74.87B 461B 178B 2,123B 187B 183B 7,713B | P/E ratio 2025 * |
100x | P/E ratio 2026 * | 58.4x |
|---|---|---|---|---|---|
| Enterprise value | 51.76B 44.03B 41.2B 38.68B 71.25B 4,697B 77.91B 480B 186B 2,209B 194B 190B 8,026B | EV / Sales 2025 * |
9.77x | EV / Sales 2026 * | 8.19x |
| Free-Float |
35.38% | Yield 2025 * |
0.14% | Yield 2026 * | 0.27% |
Last Transcript: Galderma Group AG
| 1 day | +1.89% | ||
| 1 week | +2.40% | ||
| Current month | +4.19% | ||
| 1 month | +11.51% | ||
| 3 months | +14.33% | ||
| 6 months | +49.78% | ||
| Current year | +65.64% |
| 1 week | 162.2 |  | 168.8 |
| 1 month | 143 | | 170.1 |
| Current year | 72.7 | | 170.1 |
| 1 year | 72.7 | | 170.1 |
| 3 years | 60 | | 170.1 |
| 5 years | 60 | | 170.1 |
| 10 years | 60 | | 170.1 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.89% | +2.40% | +84.67% | - | 48.81B | |
| +0.85% | +0.12% | +8.69% | +4.98% | 232B | |
| -1.07% | +0.61% | -5.04% | +14.84% | 18.37B | |
| 0.00% | +3.94% | -12.98% | -62.56% | 6.25B | |
| +0.74% | -1.29% | +9.95% | -8.09% | 5.14B | |
| +2.93% | -3.44% | -44.11% | +39.58% | 4.55B | |
| +0.53% | -1.91% | +136.68% | - | 4.32B | |
| -1.51% | -3.45% | -28.68% | -43.45% | 3.78B | |
| +1.86% | -4.93% | -56.27% | -59.80% | 2.82B | |
| -0.26% | +2.34% | -38.92% | -10.80% | 2.7B | |
| Average | +0.60% | -1.02% | +5.40% | -15.66% | 32.83B | |
| Weighted average by Cap. | +0.88% | -0.45% | +18.40% | +2.95% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.2B 4.42B 4.14B 3.89B 7.16B 472B 7.82B 48.23B 18.64B 222B 19.5B 19.09B 806B | 6.17B 5.25B 4.91B 4.61B 8.49B 560B 9.29B 57.24B 22.13B 263B 23.15B 22.66B 957B |
| Net income | 552M 470M 439M 413M 760M 50.1B 831M 5.12B 1.98B 23.56B 2.07B 2.03B 85.6B | 891M 758M 710M 666M 1.23B 80.88B 1.34B 8.27B 3.2B 38.04B 3.34B 3.27B 138B |
| Net Debt | 2.02B 1.72B 1.61B 1.51B 2.78B 183B 3.04B 18.71B 7.23B 86.08B 7.57B 7.41B 313B | 1.25B 1.06B 993M 933M 1.72B 113B 1.88B 11.58B 4.47B 53.26B 4.68B 4.58B 194B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-15 | 166.70 CHF | +1.89% | 361,242 |
| 25-12-12 | 163.60 CHF | +0.25% | 343,655 |
| 25-12-11 | 163.20 CHF | -2.74% | 359,711 |
| 25-12-10 | 167.80 CHF | +1.39% | 464,983 |
| 25-12-09 | 165.50 CHF | +0.61% | 343,034 |
Delayed Quote Swiss Exchange, December 15, 2025 at 11:30 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GALD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition